Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II (original) (raw)

Abstract

Using immunohistochemistry, we examined the localization of four types of proline-directed kinases in the brains of control rats and in the brains of non-demented aged human subjects, subjects with Alzheimer’s disease and those with Down’s syndrome. The four kinases were: cyclin-dependent kinase (cdk) 5, a component of tau protein kinase (TPK) II; TPK I/glycogen synthase kinase (GSK)-3β; GSK-3α; and mitogen-activated protein kinase (MAPK/ERK2). Each of these kinases has been reported to promote the hyperphosphorylation of tau protein in vitro. The kinases were located essentially in neurons, although the intensity and distribution of labeling varied. Antiserum for cdk5 showed the most preferential and consistent labeling of intraneuronal neurofibrillary tangles (NFT). Antiserum for TPK I/GSK-3β also labeled intraneuronal NFT. Double immunolabeling for TPK I/GSK-3β and tau1 showed that TPK I/GSK-3β was closely associated with NFT. Antiserum for GSK-3α labeled neurons weakly, and the intensity of labeling did not differ between neurons with and without NFT. Antiserum for MAPK labeled neurons in superficial cortical layers, but NFT appeared in both superficial and deep cortical layers. These findings suggest that cdk5 and TPK I/GSK-3β are the critically important kinases for the generation in vivo of hyperphosphorylated tau, the main component of the paired helical filaments in NFT.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. College of Medical Care and Technology, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371, Japan E-mail: yamaguti@news.sb.gunma-u.ac.jp, , , , , , JP
    Haruyasu Yamaguchi
  2. Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida-shi, Tokyo 194, Japan Fax: 81-427-29-1252, , , , , , JP
    Koichi Ishiguro, Tsuneko Uchida, Akihiko Takashima & K. Imahori
  3. Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA, , , , , , US
    Cynthia A. Lemere

Authors

  1. Haruyasu Yamaguchi
    You can also search for this author inPubMed Google Scholar
  2. Koichi Ishiguro
    You can also search for this author inPubMed Google Scholar
  3. Tsuneko Uchida
    You can also search for this author inPubMed Google Scholar
  4. Akihiko Takashima
    You can also search for this author inPubMed Google Scholar
  5. Cynthia A. Lemere
    You can also search for this author inPubMed Google Scholar
  6. K. Imahori
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 3 January 1996 / Revised, accepted: 11 March 1996

Rights and permissions

About this article

Cite this article

Yamaguchi, H., Ishiguro, K., Uchida, T. et al. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II.Acta Neuropathol 92, 232–241 (1996). https://doi.org/10.1007/s004010050513

Download citation